Krones Ag Adr (KRNTY) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

It's one o'clock, so good afternoon and a warm welcome from my side. My name is Olaf Scholz, Head of Investor Relations here at Crohn's. In a challenging macroeconomic environment with global uncertainties, we have confirmed today our financial targets for 2025. And Crohn's has also continued its profitable growth path. Today, Christoph Kleck and Uta Anders will give you more details about these figures and will give you also additional information. After the presentation, you will have the opportunity to ask questions. I think you also know how the Q&A session will work, so please use the function raise your hand in Teams or simply just a short email and then I will hand over to you. Additionally, be reminded that this meeting will not be recorded and it is also not allowed to record the meeting. Please also deactivate any functions of recording at Teams. So after these words in the beginning, I want to hand over to Christoph Klenk, CEO, to start the presentation. Christoph, the floor is yours. Ola, thanks a lot. A warm welcome on behalf of Utah and myself to today's conference call for Q3. So happy to have you. And I would like to start off with the statement, we are quite happy where we are, quite satisfied And now we are running you quite briefly through the numbers, which you know already, and then we are looking forward to the Q&A session, which we are going to have. I would like to start off with TringTech once again. I mean, most of you have been joining TringTech and have seen what we have stated there. Nevertheless, I just wanted to do a short summary on TringTech. I mean, for us, it was really an outstanding show. And this morning in the U.S.A., I would say this string tech has maybe remarked a milestone of crowns because for the first time, as we showed t...